These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4318530)

  • 1. The sequence of enhanced cellular activity and protective humoral factors in murine pertussis immunity.
    Gray DF; Cheers C
    Immunology; 1969 Dec; 17(6):889-96. PubMed ID: 4318530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage behaviour during the complaisant phase of murine pertussis.
    Cheers C; Gray DF
    Immunology; 1969 Dec; 17(6):875-87. PubMed ID: 4318529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the serologic type in experimental immunity against B. Pertussis.
    Pusztai Z; Joó I
    Prog Immunobiol Stand; 1967; 3():309-14. PubMed ID: 4314431
    [No Abstract]   [Full Text] [Related]  

  • 4. A rapid and simple method for evaluation of serum opsonic capacity against Bordetella pertussis by chemiluminescence.
    Lilius EM; Mertsola J; Leivo P; Kuronen T; Ruuskanen O
    Dev Biol Stand; 1985; 61():373-7. PubMed ID: 2872125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathogenetic significance of Bordetella pertussis toxin].
    Finger H
    Immun Infekt; 1985 Apr; 13(2):47-9. PubMed ID: 2860059
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: Protective activity of whooping-cough convalescent serum and serum-IgA level in mice infected with Bordetella pertussis.
    Pittman M
    Lancet; 1976 Jul; 2(7977):156. PubMed ID: 59233
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunity to pertussis.
    Cherry JD
    Clin Infect Dis; 2007 May; 44(10):1278-9. PubMed ID: 17443463
    [No Abstract]   [Full Text] [Related]  

  • 8. [Duration of efficiency of pertussis immunoglobulin in the passive protection tests in mice (author's transl)].
    Sabin S; Schwanig M; Schneider W
    Zentralbl Bakteriol A; 1981; 249(2):254-60. PubMed ID: 6267844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathology and immunology of Bordetella pertussis infection.
    Holt LB
    J Med Microbiol; 1972 Nov; 5(4):407-24. PubMed ID: 4345765
    [No Abstract]   [Full Text] [Related]  

  • 10. Delayed hypersensitivity in mature pulmonary pertussis.
    Cheers C
    Aust J Exp Biol Med Sci; 1969 Aug; 47(4):513-20. PubMed ID: 4311514
    [No Abstract]   [Full Text] [Related]  

  • 11. The protective role of maternally derived antibodies against Bordetella pertussis in young infants.
    Heininger U; Riffelmann M; Bär G; Rudin C; von König CH
    Pediatr Infect Dis J; 2013 Jun; 32(6):695-8. PubMed ID: 23429559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cellular immune response to Bordetella pertussis in two children with whooping cough.
    Hafler JP; Pohl-Koppe A
    Eur J Med Res; 1998 Nov; 3(11):523-6. PubMed ID: 9810032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local cellular immunity to the respiratory pathogen Bordetella pertussis: role of costimulatory molecules.
    McGuirk P; Mahon BP; Griffin F; Mills KH
    Biochem Soc Trans; 1997 Feb; 25(1):124S. PubMed ID: 9057022
    [No Abstract]   [Full Text] [Related]  

  • 14. Dynamics of transplacental transmission of pertussis antibodies in premature and full-term infants.
    Nomura M; Kuno-Sakai H; Kimura M; Ichikawa I
    Tokai J Exp Clin Med; 2003 Apr; 28(1):21-6. PubMed ID: 12880300
    [No Abstract]   [Full Text] [Related]  

  • 15. Passive acquisition of protective antibodies reactive with Bordetella pertussis in newborns via placental transfer and breast-feeding.
    Quinello C; Quintilio W; Carneiro-Sampaio M; Palmeira P
    Scand J Immunol; 2010 Jul; 72(1):66-73. PubMed ID: 20591078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse and pig models for studies of natural and vaccine-induced immunity to Bordetella pertussis.
    Mills KH; Gerdts V
    J Infect Dis; 2014 Apr; 209 Suppl 1():S16-9. PubMed ID: 24626866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified state of susceptibility to histamine in mice treated with Bordetella pertussis during the neonatal period.
    Poszgi N; David C; Ghyka G; Marion M; Andreescu V; Caffé I; Olinescu A
    Z Immunitatsforsch Allerg Klin Immunol; 1970 Oct; 140(4):326-34. PubMed ID: 4321232
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunity to pertussis. Not all virulence factors are protective antigens.
    Robbins JB; Schneerson R; Bryla DA; Trollfors B; Taranger J; Lagergård T
    Adv Exp Med Biol; 1998; 452():207-18. PubMed ID: 9889975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting to Fcgamma receptors, but not CR3 (CD11b/CD18), increases clearance of Bordetella pertussis.
    Hellwig SM; van Oirschot HF; Hazenbos WL; van Spriel AB; Mooi FR; van De Winkel JG
    J Infect Dis; 2001 Mar; 183(6):871-9. PubMed ID: 11237803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pitfalls in the preparation of monotypic agglutinating antisera for Bordetella pertussis.
    Holt LB
    J Med Microbiol; 1968 Nov; 1(2):169-80. PubMed ID: 4318535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.